The Covid-19 Early Treatment Fund was launched to provide funding for research in order to "find an existing drug or drug combination that, when given early, reduces hospitalization…
Phase 3 ASCERTAIN Trial Shows Promising Results with Oral Decitabine and Cedazuridine Combination for the Treatment of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia
